Nurse Practitioner, Family · Miami, FL
NPI
1730843194
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1120 NW 14th St
Miami, FL, 33136
Phone (305) 243-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
594 services
Medicare patients, 2024
319
Average age 76
Drug cost, 2024
$4.0M
6,126 prescriptions
Company payments, 2025
$6,588
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexandra Ingram was code 99214 (office e&m - established), 262 times for 199 patients. In total Alexandra Ingram billed 594 services in 13 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 262 | 199 | $77.19 | $20K |
| 99213 Office E&M - Established | Office | 140 | 118 | $50.08 | $7,011 |
| 99215 Office E&M - Established | Office | 65 | 54 | $108.54 | $7,055 |
By year: 2022 $7,686 for 77 services; 2023 $31K for 403 services; 2024 $36K for 594 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexandra Ingram prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,243 prescriptions and refills. In total Alexandra Ingram wrote 6,126 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,243 | 2,921 | 475 | $35K |
| Rytary Carbidopa/Levodopa | 325 | 440 | 88 | $368K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 301 | 631 | 101 | $14K |
| Clonazepam Generic | 241 | 272 | 80 | $2,126 |
| Donepezil Hcl Generic | 227 | 489 | 79 | $2,270 |
| Nuplazid Pimavanserin Tartrate | 190 | 237 | 35 | $1.2M |
| Amantadine Amantadine Hcl | 166 | 354 | 65 | $12K |
| Escitalopram Oxalate Generic | 164 | 350 | 62 | $2,081 |
| Trazodone Hcl Generic | 144 | 288 | 55 | $1,200 |
| Botox Onabotulinumtoxina | 127 | 374 | 63 | $158K |
| Rivastigmine Rivastigmine Tartrate | 126 | 226 | 38 | $7,053 |
| Quetiapine Fumarate Generic | 126 | 243 | 51 | $3,375 |
| Gocovri Amantadine Hcl | 125 | 169 | 26 | $500K |
| Primidone Generic | 119 | 257 | 44 | $2,671 |
| Rasagiline Mesylate Generic | 118 | 320 | 51 | $25K |
Brand drugs: 1,477 claims; generic drugs: 4,649 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexandra Ingram $6,588 ($6,588 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $3,822.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $3,822 |
| Medtronic, Inc. MDT | 14 | $2,134 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $183 |
| PolyNovo North America LLC | 1 | $154 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $123 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $62.65 |
| MDD US Operations, LLC | 3 | $53.71 |
| Lilly USA, LLC LLY | 1 | $22.27 |
| Merz Pharmaceuticals, LLC | 1 | $17.51 |
| Cala Health, Inc. | 1 | $17.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.